For Cancer Care Teams

For Lumera Xpanded and Lumera NGS Profiles, each case is assigned to expert curation scientists who review and prioritize over 1500 variants, manually selecting clinically relevant biomarkers. We then employ an AI-driven platform to match NCCN Guidelines for therapy considerations, relevant clinical trials, and other therapeutic guidance. Lastly, our scientists refine the results: While AI-based tools find correlation relevance, a PhD-level curator will consider causation as well as correlation to analyze each case from a holistic genomic point of view, producing a completely personalized result - one patient at a time.

Concise and comprehensive case summaries highlight key results from all technologies employed, giving you an overview of results straight away. You'll see actionable biomarkers and other relevant findings clearly labeled within the summary report, while the full reports include additional content with in-depth information for each level of analysis. This ensures you have all the information you need, with the most relevant information right at your fingertips.